The rat as an animal model of Alzheimer's disease

被引：54
作者：
Benedikz, Eirikur [1 ]
Kloskowska, Ewa [1 ]
Winblad, Bengt [2 ]
机构：
[1] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Neurodegenerat, S-14186 Stockholm, Sweden
[2] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Kl Alzheimers Dis Res Ctr, S-14186 Stockholm, Sweden
来源：
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 2009年 / 13卷 / 06期
关键词：
Alzheimer's disease; rat; transgenic; amyloid; cholinergic; BETA-AMYLOID PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; CHOLINERGIC BASAL FOREBRAIN; TRANSGENIC RAT; CONTINUOUS-INFUSION; MEMORY DEFICITS; TRUNCATED TAU; CASCADE HYPOTHESIS; PRECURSOR PROTEIN; OXIDATIVE STRESS;
D O I：
10.1111/j.1582-4934.2009.00781.x
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
As a disease model, the laboratory rat has contributed enormously to neuroscience research over the years. It has also been a popular animal model for Alzheimer's disease but its popularity has diminished during the last decade, as techniques for genetic manipulation in rats have lagged behind that of mice. In recent years, the rat has been making a comeback as an Alzheimer's disease model and the appearance of increasing numbers of transgenic rats will be a welcome and valuable complement to the existing mouse models. This review summarizes the contributions and current status of the rat as an animal model of Alzheimer's disease.
引用
收藏
页码：1034 / 1042
页数：9
相关论文
共 108 条
[1]   The Renaissance rat [J].
Abbott, A .
NATURE, 2004, 428 (6982) :464-466
[2]   Development of transgenic rats producing human β-amyloid precursor protein as a model for Alzheimer's disease:: Transgene and endogenous APP genes are regulated tissue-specifically [J].
Agca, Cansu ;
Fritz, Jason J. ;
Walker, Lary C. ;
Levey, Allan I. ;
Chan, Anthony W. S. ;
Lah, James J. ;
Agca, Yuksel .
BMC NEUROSCIENCE, 2008, 9 (1) :28
[3]  
Almkvist O, 1996, ACTA NEUROL SCAND, V93, P63
[4]   NEURONAL LOSS, NEUROFIBRILLARY TANGLES AND GRANULOVACUOLAR DEGENERATION IN HIPPOCAMPUS WITH AGING AND DEMENTIA - QUANTITATIVE STUDY [J].
BALL, MJ .
ACTA NEUROPATHOLOGICA, 1977, 37 (02) :111-118
[5]   THE CHOLINERGIC HYPOTHESIS - A HISTORICAL OVERVIEW, CURRENT PERSPECTIVE, AND FUTURE-DIRECTIONS [J].
BARTUS, RT ;
DEAN, RL ;
PONTECORVO, MJ ;
FLICKER, C .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 444 (MAY) :332-358
[6]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[7]   SPECIFICITY OF 192 IGG-SAPORIN FOR NGF RECEPTOR-POSITIVE CHOLINERGIC BASAL FOREBRAIN NEURONS IN THE RAT [J].
BOOK, AA ;
WILEY, RG ;
SCHWEITZER, JB .
BRAIN RESEARCH, 1992, 590 (1-2) :350-355
[8]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[9]   Tau alteration and neuronal degeneration in tauopathies: mechanisms and models [J].
Brandt, R ;
Hundelt, M ;
Shahani, N .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2005, 1739 (2-3) :331-354
[10]   The neurochemical and behavioral effects of beta-amyloid peptide(25-35) [J].
Chen, SY ;
Wright, JW ;
Barnes, CD .
BRAIN RESEARCH, 1996, 720 (1-2) :54-60
12345678910